NCT06280391: An ongoing trial by Sanofi
This trial is ongoing. It must report results 2 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06280391 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of Itepekimab, in Participants With Non-cystic Fibrosis Bronchiectasis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 20, 2024 |
| Completion date | Sept. 16, 2025 |
| Required reporting date | Sept. 16, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 19, 2026 |
| Days late | None |